1Burtdgaard JR, Sengelov H, Borregaard N, et al. Molecular cloning and expression of a cDNA encoding NGAL: a lipocalin expressed in human neutrophils [ J]. J biochem Biophys Res Commun, 1994,202 (3) :1468.
2Kjeldsen L, Johnsen AH, Sengelov H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase[ J ]. J Siol Chem, 1993,268 ( 14 ) : 10425.
3JB Cowland, N Borregaard. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase - associated lipocalin from humans [ G ]. Genomics, 1997,45 ( 1 ) : 17.
4Schmidt - Ott KM, Moil K. Dual action of neutrophil geiatinsse - associated Lipocalin[ J]. J Am Soc Nephrol,2007,18(2) :407.
5Harris D C, Tay Y C, Chen J. Mechanisms of iron - induced proximal tubule injury in rat remnant kidney[ J]. Am J Physiol, 1995,269 (2 pt 2) :F218.
6Mori K, Lee H T, Rapoport D, et al. Endocytic delivery of lipocalin - siderophore - iron complex rescurs the kidney from ischemia - reperfusion injury[J]. J Clin Invest,2005,115(3) :610.
7Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States[ J]. JAMA, 2007,298:2038.
8Bolignano D, Laequaniti A. Neutrophil gelatinase - associated lipocalin (NGAL) and progression of chronic kidney disease[ J]. J Clin Nephrol,2009,4(2) :337.
9Coekwell P, Howie AJ, A du D, et al. In situ analysis of C2C ehemokine mRNA in human glomeruloneph ritis[J]. Kidney Int,1998,54:827.
1A. Friedl,S.P. Stoesz,P. Buckley,M.N. Gould. Neutrophil Gelatinase-associated Lipocalin in Normal and Neoplastic Human Tissues. Cell Type-specific Pattern of Expression[J] 1999,The Histochemical Journal(7):433～441
3] Kjeldsen L, Johnsen AH, Sengelov, et al. Isolation andprimary stuc- ture of NGAL, a novel protein associated with neutrophil gelatinase. Biol Chem, 1993,268 ( 14 ) : 10425-10432.
4Roudkenar MH, Kuwahara Y, Baba T, et al. Oxidative stress induced lipocalin 2 gene expression: addressing its expression under the harm- ful conditions. J Radiat Res,2007,48( 1 ) :39-44.
5Molitoris BA. Transitioning to therapy in ischemic acute renal fail- ure. Am Soc Nephrol,2003,14( 1 ) :265-267.
6Bolignano D, Donato V, Lacquaniti A. Neutrophil gelatinase-associ- ated lipocalin (NGAL)in human neoplasias: A new protein enters the scene. Cancer Lett,2010,288 ( 1 ) : 10-16.
7Zhang XF, Zhang Y, Zhang XH. Clinical significance of neutrophil gelatinase2associated lipocalin(NGAL) expression in primary rectal cancer. BMC Cancer,2009,9 : 134.
8Hu L, HittelmanW, Lu T, et al. NGAL decreases Ecadherin mediated cell2cell adhesion and increases cell motility and invasion through Racl in colon carcinoma cells. Lab Invest, 2009,89 ( 5 ) :531-548.
9Devarajan P. Neutrophil gelatinase-associated lipocalin ( NGAL ) : a new marker of kidney disease. Scand J Clin Lab Invest, 2008,241 ( Suppl ) : 89 -94.
10Mishra J, Ma Q, Prada A, et al Indentification of neutrophil gelatinase associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol,2003,14(10) :2534-2543.
